The bankers said ACL serviced more than 85 hospitals, making it the largest private pathology provider for hospitals, including long-term contracts with Healthscope and St John of God. There was news of $80 million to upgrade the company’s central labs, including a “highly automated” lab in Adelaide, and use of Siemens and Roche platforms.
Revenue has increased to about $500 million a year, up from $262 million in 2016, helped along by acquisitions of St John of God and Perth Pathology in late 2016, while growth options included a recently won Defence contract, and its preferred relationship with Australia’s fastest growing GP network.
Fresh face wanted
What the flyer doesn’t talk about – but is material to the process – is the Australian Competition and Consumer Commission. Australian pathology is highly consolidated, with the big three players Sonic Healthcare (44.5 per cent of the market), Healius (34.4 per cent) and